| CPC A61F 9/0017 (2013.01) [A61F 2/0095 (2013.01); A61F 2/142 (2013.01); A61F 2/148 (2013.01); A61L 27/3604 (2013.01); A61B 2017/00969 (2013.01)] | 14 Claims |
|
1. A needle injector for endothelial keratoplasty in combination with an injector carrier comprising:
(a) a first portion comprising a first conduit having a first end, a second end, and a first conduit maximum diameter;
(b) a second portion comprising a second conduit having a first end, a second end, and a second conduit maximum diameter, wherein
(i) the maximum diameter of the second conduit second end is less than the first conduit maximum diameter, and wherein
(ii) the first end of the second conduit is fluidly coupled to the second end of the first conduit, and
(iii) the second conduit defines a chamber having an interior diameter and a chamber length that are sized to store an endothelium tissue layer coupled to a Descemet membrane and sized to provide corneal storage media irrigation to the ophthalmic tissue graft; and
(c) a third portion comprising a third conduit having a first end with a first opening and a second end, and a third portion length that extends along a straight line from the first end to the second end such that the third portion is not curved, wherein
(i) the first end of the third conduit is fluidly coupled to the second end of the second conduit, and wherein
(ii) the second end of the third conduit comprises a second opening configured to dispense an endothelium tissue layer coupled to a Descemet membrane, and wherein
(iii) the third portion does not comprise any openings along the length, and wherein
(iv) the first opening and the second opening are the only structures of the third portion through which fluid can pass; and
(d) an injector carrier, the injector carrier comprising
(i) a container having an opening,
(ii) cap configured to seal the opening of the container, and
(iii) at least the first portion and the second portion disposed within the container.
|
|
13. A method for performing endothelial keratoplasty for an eye of a patient comprising:
(a) providing a needle injector comprising
(i) a first portion comprising a first conduit having a first end, a second end, and a first conduit maximum diameter,
(ii) a second portion comprising a second conduit comprising (A) a first end, (B) a second end having a second conduit end maximum diameter, (C) a second portion length that extends between the first end of the second conduit and the second end of the second conduit, wherein
the first end of the second conduit is fluidly coupled to the second end of the first conduit,
the second conduit end maximum diameter is less than the first conduit maximum diameter,
the second conduit defines a chamber, wherein (I) the chamber extends at least partially along the second portion length, (II) the chamber tapers from a wider end to a narrower end, wherein the wider end is closer to the first portion than the narrower end, and (III) the chamber has an interior diameter and a chamber length that are sized to store an ophthalmic tissue graft and sized to provide corneal storage media irrigation to the ophthalmic tissue graft; and
(iii) a third portion comprising (A) a third conduit having a first end with a first opening and a second end with a second opening, and further comprising (B) a third portion length that extends along a straight line from the first end to the second end such that the third portion is not curved, wherein
the first end of the third conduit is fluidly coupled to the second end of the second conduit,
the second end of the third conduit comprises an opening having a beveled surface that is structured to penetrate eye tissue to dispense an endothelium tissue layer coupled to a Descemet membrane,
wherein the endothelium tissue layer coupled to the Descemet membrane is positioned within the chamber,
the third portion does not comprise any openings along the length, and
the third conduit first opening and second opening are the only structures of the third portion through which fluid can pass;
(b) inserting the second end of the third conduit into the eye of the patient, wherein the second end of the third conduit penetrates the eye of the patient; and
(c) dispensing the endothelium tissue layer coupled to the Descemet membrane from the chamber of the needle injector through the third conduit of the needle injector into the eye of the patient.
|